stor

The Angel Journal

EquityNet

Become a
CFI Sponsor!


CLICK for
information

Merchant Services  

Dan Broderick Dan Broderick
Managing Director
Mason Wells
Milwaukee, WI

As a Managing Director of Mason Wells Venture Funds, Mr. Broderick is primarily responsible for co-managing the venture investment activities of the firm. In this capacity, Mr. Broderick is responsible for initiating investment opportunities, structuring and negotiating transactions, serving on the Board of Directors of the portfolio companies, working with portfolio company management teams to create shareholder value, and arranging for the orderly disposition of investments at a profit to the fund. Mr. Broderick is a member of the Board of Mason Wells, Inc., and the Management Committee of the firm as well as the Investment Committee for the venture funds.

Mr. Broderick has over 17 years of experience in the biomedical and venture capital industry. Prior to joining Mason Wells in 2000, Mr. Broderick spent 18 years at Mayo Clinic in Rochester, Minnesota were he served as Director of the Office of Technology Commercialization and played a key role in launching Mayo's Venture Fund. His leadership, scientific and business skills helped develop the Mayo Clinic multi-campus technology commercialization organization into one of the most successful and profitable of its kind. He has personally evaluated the commercial potential of hundreds of technologies in virtually every medical specialty. He has been directly responsible for negotiating and consummating over one hundred different commercialization agreements. He has extensive experience with technology evaluation, market assessment, negotiations, academic institution technology transfer and intellectual property management.

While at Mayo Mr. Broderick served on the Board of Directors of Intratherapeutics Inc., CNSoftware, Medintell, Inc., as well as the Operations Committee of Aesgen, Inc. Since joining Mason Wells, Mr. Broderick has served as a member of the Board of Directors for Gala Design, Inc., and Mezzia, Inc., and currently serves on the Boards of OpGen, Inc., Deltanoid Pharmaceuticals, Inc., and ZyStor Therapeutics, Inc. In addition, Mr. Broderick is a co-founder and currently serves as President of the Mid-America Healthcare Investor Network (MHIN), is Vice President of the Wisconsin Venture Capital Association, and is a member of the National Venture Capital Association (NVCA) Board of Directors.

Mr. Broderick received a Bachelors Degree from Iowa State University and an Appointment to the Staff at Mayo Clinic.

Capital Formation Institute, Inc.
a 501(c)(3) non-profit organization
Office of Science, Technology Transfer and Economic Outreach
University at Buffalo, 1576 Sweet Home Rd., Amherst, NY 14228

Subscribe to AudioBlog


Contact us at dloague@cfi-institute.org

©2006 CFI
All information herein provided as a public service